Delivery Order SPE2DB20D2014-SPE2DB24FA74N

Award Date 1/5/24
Potential Completion Date 1/8/24
Potential Value $9.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,701.15, is for the delivery of 4563063713 CITALOPRAM HBR 40 MG TABLET 100S. The contract is a firm fixed-price delivery order with an ultimate completion date of December 12, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,065.80, is for the supply of 4563866770 CITALOPRAM HBR 40 MG TABLET 500S. The contract is a firm fixed-price delivery order, with a completion date of March 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award, valued at $13,598.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567090503 - CITALOPRAM HBR 40 MG TABLET 500S, with an ultimate completion date of January 30, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not associated with any set-aside designation. AmerisourceBergen Drug Corp, a...
This federal contract award, valued at $2,515.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,088,187 units of Citalopram HBR 40 mg tablets, a medication used to treat mental health conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.28 firm-fixed-price delivery order is for the supply of 4,567,059,343 units of Citalopram HBR 40 mg tablets. This contract is not designated as a set-aside. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $3,818.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,841,042 units of the pharmaceutical Citalopram HBR 40 mg tablets, with a completion date of November 17, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,397.81, is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CITALOPRAM HBR 40 MG TABLET 500S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,473,890 units of Citalopram HBR 40 mg tablets. The fixed-price delivery order has a ceiling value of $28,331.92 and an ultimate completion date of October 16, 2023. This award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through...
This federal contract award, valued at $10,286.25, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. The contract is for the delivery of 4562731594 CITALOPRAM HBR 40 MG TABLET 500S, a pharmaceutical product...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,680,284 units of Citalopram HBR 40 mg tablets. The $3,805.46 firm fixed-price Delivery Order has a completion date of February 16, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that provides a comprehensive range of pharmaceutical products and medical supplies to...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FA74N
    Delivery Order

This federal contract award, valued at $9,396.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of 4563250151 CITALOPRAM HBR 40 MG TABLET 500S, with a period of performance through January 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 9:52 AM